[1]
|
R. Amsel, A. Totten, D. Eschenbach and K. Holmes, “Non-Specific Vaginitis, Diagnostic Criteria Microbial and Epidemiologic Associations,” American Journal of Medicine, Vol. 74, No. 1, 1983, pp. 14-22.
doi:10.1016/0002-9343(83)91112-9
|
[2]
|
J. Atashili, M. Ndumbe and J. Smith, “Bacterial Vaginosis and HIV Acquisition: A Meta-Analysis of Published Studies,” Journal of Infectious Diseases, Vol. 22, No. 12, 2008, pp. 1493-1501.
|
[3]
|
E. Allworth and F. Peipert, “Prevalence of Bacterial Vaginosis: 2001-2004 National Health and Nutrition Examination Survey Data,” Obstetrics & Gynecology, Vol. 109, No. 1, 2007, pp. 114-120.
doi:10.1097/01.AOG.0000247627.84791.91
|
[4]
|
M. Brotman, M. Klebanoff and R. Nansel, “Bacterial Vaginosis Assessed by Gram Stain and Diminished Colonization Resistance to Incident Gonococcal, Chlamydial, and Trichomonal Genital Infection,” Journal of Infectious Diseases, Vol. 202, No. 12, 2010, pp. 1907-1915.
doi:10.1086/657320
|
[5]
|
E. Bukusi, R. Cohen, S. Meier, G. Waiyaki, R. Nguti, N. Njeri and K. Holmes, “Bacterial Vaginosis: Risk Factors among Kenyan Women and Their Male Partners,” Sexually Transmitted Disease, Vol. 33, 2006, pp. 361-367.
|
[6]
|
J. Christopher and V. Snehalata, “Syndromic Management of Vaginal Discharge among Women in a Reproductive Health Clinic in India,” Sexually Transmitted Disease, Vol. 76, 2000, pp. 303-306.
|
[7]
|
O. Fernández-Limia, C. Villar and R. Faure, “Prevalence of Trichomoniasis, Bacterial Vaginosis and Candidiasis in Women Attending Sexual Transmitted Infections and Gynecologic Clinic Using an Immunologic Latex Agglutination Test,” American Journal of Obstetrics & Gynecology, Vol. 166, 2007, pp. 938-934.
|
[8]
|
N. Fredricks, L. Fiedler and M. Marrazzo, “Molecular Identification of Bacteria Associated with Bacterial Vaginosis,” The New England Journal of Medicine, Vol. 353, No. 18, 2005, pp. 1899-1911.
doi:10.1056/NEJMoa043802
|
[9]
|
P. Nugent, A. Krohn and L. Hillier, “Reliability of Diagnosing Bacterial Vaginosis is Improved by a Standardized Method of Gram Stain Interpretation,” Journal of Clinical Microbiology, Vol. 29, No. 2, 1991, pp. 297-301.
|
[10]
|
http://www.measuringusability.com/wald.htm
|
[11]
|
K. Fonck, N. Kidula, N. Temmerman and W. Jaoko, B. Estimable and P. Claeys, “Sexually Transmitted Infections and Pelvic Inflammatory Disease,” American Journal of Epidemiology, Vol. 162, 2000, pp. 585-590.
|
[12]
|
H. Koumans, M. Sternberg and C. Bruce, “The Prevalence of Bacterial Vaginosis in the United States, 2001-2004; Associations with Symptoms, Sexual Behaviors, and Reproductive Health,” Sexually Transmitted Disease, Vol. 34, 2007, pp. 864-869.
|
[13]
|
E. H. Koumans, L. E. Markowitz, V. Hogan and CDC BV Working Group, “Indications for Therapy and Treatment Recommendations for Bacterial Vaginosis in Non Pregnant and Pregnant Women: A Synthesis of Data,” Clinical Infectious Diseases, Vol. 35, No. 2, 2002, pp. 152-172. doi:10.1086/342103
|
[14]
|
J. Bornstein and H. Abramovici, “The Classis Approach to Diagnosis of Vulvo-Vaginitis: A Critical Analysis,” Infect Disease in Obstetrics and Gynecology, Vol. 164, No. 2, 2001, pp. 105-111.
doi:10.1155/S1064744901000187
|
[15]
|
L. Gardner and D. Dukes, “Haemophilus vaginalis vaginitis: A Newly Defined Specific Infection Previously Classified Non-Specific Vaginitis,” American Journal of Obstetrics and Gynecology, Vol. 69, 1955, pp. 962-976.
|
[16]
|
F. Lamont, J. Sobel and A. Akins, “The Vaginal Microbiome: New Information about Genital Tract Flora Using Molecular Based Techniques,” BJOG, Vol. 118, No. 5, 2011, pp. 533-549.
doi:10.1111/j.1471-0528.2010.02840.x
|
[17]
|
S. Lofmark, C. Edlund and E. Nord, “Metronidazole Is Still the Drug of Choice for Treatment of Anaerobic Infections,” Clinical Infectious Diseases, Vol. 50, No. 1, 2010, pp. S16-S23. doi:10.1086/647939
|
[18]
|
P. Menard, F. Fenollar, M. Henry, F. Bretelle and D. Raoult, “Molecular Quantification of Gardnerella vaginalis and Atopobium vaginae Loads to Predict Bacterial Vaginosis,” Clinical Infectious Diseases, Vol. 47, No. 1, 2008, pp. 33-43. doi:10.1086/588661
|
[19]
|
H. Mikamo, K. Kawazoe, K. Izumi, K. Watanabe, K. Ueno and T. Tamaya, “Comparative Study on Vaginal or Oral Treatment of Bacterial Vaginosis,” Chemotherapy, Vol. 43, No. 1, 1997, pp. 60-68. doi:10.1159/000239537
|
[20]
|
J. Sobel, F. Peipert and J. McGregor, “Efficacy of Clindamycin Vaginal Ovule (3-Day Treatment) vs Clindamycin Vaginal Cream (7-Day Treatment) in Bacterial Vaginosis,” Infectious Diseases in Obstetrics and Gynecology, Vol. 9, No. 1, 2001, pp. 9-15.
doi:10.1155/S1064744901000035
|
[21]
|
E. Calzolari, R. Masciangelo and V. Milite, “Bacterial Vaginosis and Contraceptive Methods,” American Journal of Obstetrics and Gynecology, Vol. 70, No. 3, 2000, pp 341-346.
|
[22]
|
R. Cohen, P. Garcia and K. Nelson, “Bacterial Vaginosis and HIV Seroprevalence among Female Commercial Sex Workers in Chiang Mai, Thailand,” American Journal of Obstetrics and Gynecology, Vol. 9, 1992, pp. 1093-1097.
|
[23]
|
P. Hay, N. Ugwumadu and T. Manyonda, “Oral Clindamycin Prevents Spontaneous Preterm Birth and Mid Trimester Miscarriage in Pregnant Women with Bacterial Vaginosis,” The International Journal of STD & AIDS, Vol. 12, No. 2, 2001, pp. 70-71.
|
[24]
|
C. Miller, H. Swygard and M. Hobbs, “The Prevalence of Trichomoniasis in Young Adults in the United States,” Sexually Transmitted Disease, Vol. 32, 2005, pp. 593-598.
|